Triangle Securities Wealth Management Purchases 767 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Triangle Securities Wealth Management lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 18.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,887 shares of the healthcare conglomerate’s stock after acquiring an additional 767 shares during the period. Triangle Securities Wealth Management’s holdings in UnitedHealth Group were worth $2,472,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the stock. HB Wealth Management LLC boosted its holdings in UnitedHealth Group by 2.0% in the fourth quarter. HB Wealth Management LLC now owns 51,986 shares of the healthcare conglomerate’s stock worth $26,298,000 after acquiring an additional 1,029 shares in the last quarter. Trust Co. of Vermont lifted its holdings in shares of UnitedHealth Group by 9.1% in the 4th quarter. Trust Co. of Vermont now owns 38,993 shares of the healthcare conglomerate’s stock worth $19,725,000 after purchasing an additional 3,268 shares in the last quarter. Sanibel Captiva Trust Company Inc. raised its holdings in shares of UnitedHealth Group by 3.4% in the 4th quarter. Sanibel Captiva Trust Company Inc. now owns 69,016 shares of the healthcare conglomerate’s stock worth $34,912,000 after acquiring an additional 2,272 shares during the last quarter. Howard Financial Services LTD. increased its holdings in UnitedHealth Group by 8.8% during the 4th quarter. Howard Financial Services LTD. now owns 408 shares of the healthcare conglomerate’s stock worth $206,000 after purchasing an additional 33 shares in the last quarter. Finally, Verity & Verity LLC lifted its holdings in shares of UnitedHealth Group by 36.9% in the fourth quarter. Verity & Verity LLC now owns 2,052 shares of the healthcare conglomerate’s stock valued at $1,038,000 after purchasing an additional 553 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Barclays dropped their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday. KeyCorp reaffirmed an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Morgan Stanley decreased their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Finally, Truist Financial lowered their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Two research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Trading Down 0.1 %

Shares of UNH opened at $510.03 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a market capitalization of $469.37 billion, a P/E ratio of 33.23, a P/E/G ratio of 1.42 and a beta of 0.62. The firm’s 50 day simple moving average is $549.37 and its 200 day simple moving average is $562.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the firm posted $5.83 EPS. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.